Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001859389 | SCV002283674 | pathogenic | Hereditary spastic paraplegia 39 | 2022-11-01 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PNPLA6 protein function. ClinVar contains an entry for this variant (Variation ID: 1195875). This variant is also known as c.3134C>T (p.Ser1045Leu). This missense change has been observed in individual(s) with Boucher-Neuhäuser syndrome and/or Oliver-McFarlane syndrome (PMID: 24355708, 25267340, 33141049). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs541098659, gnomAD 0.003%). This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 997 of the PNPLA6 protein (p.Ser997Leu). |
Gene |
RCV001559127 | SCV001781212 | not provided | Ataxia-hypogonadism-choroidal dystrophy syndrome | no assertion provided | literature only | To date reported only in compound heterozygotes with Boucher-Neuhauser syndrome |